Interatrial shunt therapy represents an innovative device-based approach to alleviating elevated left atrial pressure in patients with heart failure, particularly those with preserved ejection ...
In patients with heart failure (HF), a lower tricuspid annular plane systolic excursion (TAPSE) to pulmonary artery systolic pressure (PASP) ratio — a marker of right ventricular-PA (RV-PA) coupling — ...
FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial. In its premarket approval application for the ...
An FDA advisory panel gave a unanimous verdict for an interatrial shunt in heart failure: no way. All 15 members of the Circulatory System Devices Panel of the Medical Devices Advisory Committee on ...
Patent foramen ovale (PFO) is a common congenital cardiac anomaly, generally responsible for cryptogenic stroke. Still, it can cause severe positional hypoxia via a right-to-left shunt if associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results